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Abstract
Background: Senescent cells are well-recognized in the aging/degenerating human disc. Senescent cells are
viable, cannot divide, remain metabolically active and accumulate within the disc over time. Molecular analysis of
senescent cells in tissue offers a special challenge since there are no cell surface markers for senescence which
would let one use fluorescence-activated cell sorting as a method for separating out senescent cells.
Methods: We employed a novel laser capture microdissection (LCM) design to selectively harvest senescent and
non-senescent annulus cells in paraffin-embedded tissue, and compared their gene expression with microarray
analysis. LCM was used to separately harvest senescent and non-senescent cells from 11 human annulus specimens.
Results: Microarray analysis revealed significant differences in expression levels in senescent cells vs non-senescent
cells: 292 genes were upregulated, and 321 downregulated. Genes with established relationships to senescence
were found to be significantly upregulated in senescent cells vs. non-senescent cells: p38 (MPAK14), RB-Associated
KRAB zinc finger, Discoidin, CUB and LCCL domain, growth arrest and DNA-damage inducible beta, p28ING5,
sphingosine-1-phosphate receptor 2 and somatostatin receptor 3; cyclin-dependent kinase 8 showed significant
downregulation in senescent cells. Nitric oxidase synthase 1, and heat shock 70 kDa protein 6, both of which were
significantly down-regulated in senescent cells, also showed significant changes. Additional genes related to
cytokines, cell proliferation, and other processes were also identified.
Conclusions: Our LCM-microarray analyses identified a set of genes associated with senescence which were
significantly upregulated in senescent vs non-senescent cells in the human annulus. These genes include p38 MAP
kinase, discoidin, inhibitor of growth family member 5, and growth arrest and DNA-damage-inducible beta. Other
genes, including genes associated with cell proliferation, extracellular matrix formation, cell signaling and other cell
functions also showed significant modulation in senescent vs non-senescent cells. The aging/degenerating disc
undergoes a well-recognized loss of cells; understanding senescent cells is important since their presence further
reduces the disc’s ability to generate new cells to replace those lost to necrosis or apoptosis.
Background
Cell senescence (also termed replicative senescence)
occurs when normal cells stop dividing. This phenom-
enon was initially described more than 40 years ago dur-
ing studies of cultured human fibroblasts [1]. Senescent
cells are viable, but exhibit alterations in phenotype and
altered gene expression patterns [2-5]. Senescent cells
may have altered responsiveness to external stimuli and
may secrete factors which can influence neighboring
cells or their nearby extracellular matrix (ECM). There
is currently a great deal of interest in the manner in
which cell senescence may contribute to age-associated
loss of function or age-related pathology in vivo, and
molecular studies are directed towards elucidating
* Correspondence: helen.gruber@carolinashealthcare.org
Department of Orthopaedic Surgery, Carolinas Medical Center, Charlotte, N.
C., USA
Gruber et al. BMC Biotechnology 2010, 10:5
http://www.biomedcentral.com/1472-6750/10/5
© 2010 Gruber et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.mechanisms and pathways which activate the senescence
program in cells [6].
The current views of cell senescence not only recog-
nize that it is a condition in which cells can no longer
respond to mitogenic signals and thus cannot prolifer-
ate, but also point out that senescence also is associated
with alterations in nuclear structure, protein processing,
gene expression and cell metabolism. The senescent
state is a complex response to specific trigger(s) or mul-
tiple signaling pathways, including telomere uncapping,
oxidative stress, DNA damage and oncogene activation
[3,7,8]. Senescence represents a general cellular response
mechanism which, when activated, results in numerous
morphologic and functional changes [2]. There is cur-
rently no one single marker for senescent cells, but
researchers now have characterized a number of impor-
tant characteristics which have been summarized by
Campisi and d’Adda di Faggana [9] and Cichowski and
Hahn [10].
Microarray analysis, which we used in the present
work, has been shown to be a powerful analytical tool in
previous studies of cell senescence in studies of cultured
cells [11]. Shelton et al. studied senescence in three cell
types, dermal fibroblasts, retinal pigment epithelial cells,
and vascular endothelial cells [12], and Zhang et al.
examined senescent fibroblasts and mammary epithelial
cells [13]. These studies, and gene expression profiling
studies [14], showed that specific cell types have specific
patterns of up- or down-regulation of gene expression
during senescence.
In the aging intervertebral disc, there is a well-recog-
nized loss of cells, which puts the remaining cell popula-
tion at risk for any diminution in cell function. A
number of years ago, Buckwalter provided insightful
comments which pointed to the need to learn more
about this process which blocks future cell division cap-
ability in the disc and alters the cell’s functional capacity
[15,16].
A number of major studies have now verified the pre-
sence of senescent cells in the aging/degenerating
human disc. Studies by Roberts et al. have provided evi-
dence that there was a greater proportion of senescent
cells in herniated than non-herniated discs, and more
senescent cells in the nucleus pulposus compared to the
annulus [17]. Work by Le Maitre et al. showed that the
senescent cell phenotype is associated with increased
catabolism involving metalloproteinase 13 (MMP 13)
and aggrecanase (ADAMTS 5) [18]. This finding was
important because it links senescence with matrix
degradation, one of the major problems in disc degen-
eration. This study also showed that disc cells exhibit
accelerated senescence with decreased telomere length.
Studies from our laboratory have shown that the pro-
portion of senescent cells increased significantly with
increasing stages of disc degeneration (p < 0.0001) [19].
Another publication from our lab has provided addi-
tional information on disc cell senescence. Using laser
capture microdissection and microarray analysis, this
study (described in more detail below) identified two
senescence-related genes which were significantly up-
regulated in more degenerated discs compared to heal-
thier discs [20]: growth arrest-specific 1 gene (GAS)
(which inhibits DNA synthesis, inhibits cell cycle pro-
gression in vitro, and is expressed in senescent fibro-
blasts [21-23]. The second significantly upregulated gene
was lysyl oxidase-like 2 (LOXL2), which has been seen
to be expressed in senescent human fibroblasts [24,25].
More recently, we have also shown that increased cell
senescence is associated in vivo with decreased cell pro-
liferation in the degenerating annulus [26].
Since senescent cells cannot divide, they may reduce
the disc’s ability to generate new cells to replace those
lost to necrosis or apoptosis. Senescent cells also accu-
mulate over time, and their metabolic products may
contribute to pathologic changes seen in degenerating
discs. Because of the importance of senescence, in the
present study we utilize laser capture microdissection
(LCM) to specifically harvest senescent cells from the
annulus, determine gene expression patterns using
microarray analysis, and then compare and contrast the
senescent cell expression patterns with patterns from
paired non-senescent cells harvested from the same his-
tologic section.
Methods
Clinical Study Population
Experimental study of human disc specimens was
approved prospectively by the authors’ Human Subjects
Institutional Review Board at Carolinas Medical Center.
The need for informed consent was waived since disc
tissue was removed as part of routine surgical practice.
Scoring of disc degeneration utilized the Thompson
scoring system; this system scores disc degeneration
over the spectrum from a healthy disc (Thompson grade
I) to discs with advanced degeneration (grade V, the
most advanced stage of degeneration) [27]. Patient spe-
cimens were derived from surgical disc procedures per-
formed on individuals with herniated discs and
degenerative disc disease. Surgical specimens were trans-
p o r t e dt ot h el a b o r a t o r yi ns t e r i l et i s s u ec u l t u r e
medium.
Disc Specimens
Table 1 presents the subject demographic features for
specimens utilized in this study. Specimens were graded
using the Thompson scoring system [27] where Grade I
describes a healthy disc with abundant proteoglycan and
normal collagen lamellar structure; grades progress up
to Grade V which denotes a severely degenerated disc
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proteoglycan.
Study Design
In the present study we utilize LCM to specifically har-
vest senescent cells from the annulus, determine gene
expression patterns using microarray analysis, and then
compare and contrast the senescent cell expression pat-
terns with patterns from paired non-senescent cells har-
vested from the same histologic section.
Comparison of Histochemical Senescent Cell Staining with
the Technique Used for Senescence-Associated-b-
galactosidase Immunolocalization for Laser Capture
Micro-dissection
The traditional histochemical staining method which is
utilized routinely for identification of senescent cultured
cells unfortunately will not work on paraffin-embedded
tissue. Therefore, we carried out an initial study to con-
firm that the immunohistochemical method to be used
with LCM produced results which were not statistically
different from those seen with the histochemical stain-
ing procedure. For this study, we used cultured disc
cells from four surgical patients; annulus cells were
derived and passaged as previously described [28], and
assessed using a stress-induced in vitro model recently
developed in our lab [29]. Briefly, cells are plated on
multichamber slides (Lab-Tek™ Chamber Slide™ System
(Nunc, Napierville, IL)), allowed to attach, and are then
exposed to either control conditions or H2O2 exposure
as a method of exogenous production of stress-induced
premature cell senescence. Cells are exposed to 50 μM
H2O2 for 2 hours, rinsed, and allowed to grow for 3
days. At termination, cells are rinsed, fixed with 10%
neutral-buffered formalin for 10 min, and stored in 70%
ethanol until processed for either histochemical localiza-
tion of localization of senescence, or immunohistochem-
ical detection of senescence as described above.
Histochemical identification of senescent cells was
performed using the Senescent Cells Staining Kit
(Sigma, St Louis, MO) according to manufacturer’s
instructions. All reagents were provided in the kit. Cells
were washed two times in PBS and fixed in the fixative
solution for 7 minutes at room temperature. Cells were
then rinsed three times in PBS and then incubated in
the staining solution overnight at 37°C. Cells were
rinsed in PBS and counterstained with Nuclear Fast Red
(Sigma) for 5 minutes.
The percentage of senescent cells was determined for
each of four separate cultures of human annulus cells in
both control and H2O2-treated cultures.
Senescence-Associated-b-galactosidase
Immunolocalization for Laser Capture Microdissection
Specimens were fixed overnight in 10% neutral buffered
formalin (Allegiance, McGaw Park, IL), and then trans-
ferred to 70% Ethyl alcohol (AAPER, Shelbyville, KY) for
holding until processed for paraffin embedding. Speci-
mens were processed on TBS ATP1 Tissue Processor
(TBS, Durham, NC), and embedded in Paraplast Plus
(ThermoShandon, Pittsburgh, PA) paraffin. 4 μms e c -
tions were cut with a Leica (Nussloch, Germany)
RM2025 microtome using RNase-free techniques and
mounted on Superfrost Slides (Allegiance). Slides were
cut the day they were to be processed for immunohisto-
chemistry, and placed in 60°C oven for 30 minutes.
Slides were deparaffinized using the reagents provided
in the Paradise Reagent System (Molecular Devices,
Sunnyvale, CA).
The immunofluorescence procedure utilized the His-
togene LCM Immunofluorescence Staining Kit (Molecu-
lar Devices). The primary antibody; anti-b-galactosidase
(Promega, Madison, WI) was used at a dilution of 1:20
for 10 minutes. Biotinylated Link Antibody (Dako, Car-
penteria, CA) was applied for 5 minutes followed by
Table 1 Demographic Features of Subjects and Percentages of Senescent Cells *
Subject Number % Senescent Cells ** Age
(years)
Gender Site Thompson
Grade
1 68.1 28 Female L3-L4 3
2 76.4 46 Female L4-L5 4
3 71.8 56 Male L4-L5 4
4 74.5 45 Male L5-S1 4
5 80.2 54 Female C4-C5 4
6 92.0 32 Male L5-S1 4
7 64.4 56 Male L4-L5 5
8 68.6 37 Male L4-L5 3.5
9 57.1 57 Male L4-L5 3
10 46.1 26 Female L5-S1 3
11 51.8 37 Male L5-S1 3
* * L, lumbar; S, sacral; C, cervical.
** Determined from measurement of senescent cells (using SA-b-gal immunohistochemistry) on sections adjacent to those used for LCM.
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formed at 4°C. Slides were dehydrated using reagents
and protocol provided in Histogene Kit, air dried for 5
minutes, and laser capture microdissection performed as
described below.
Laser Capture Microdissection
LCM was carried out using the Arcturus PixCell lle
LCM1106. Cells were harvested using standard LCM
techniques as previously described [20]. Histologic sec-
tions adjacent to those used for LCM were first exam-
ined to ensure that only annulus regions were present.
During LCM, a special film attached to a microfuge cap
was placed on top of the section. Cells of interest were
selected for laser removal and marked by circles. When
all cells had been selected, a finely focused laser pulse
was used to melt the film and allow cells to be harvested
when the cap is removed. Senescent cells were selected
and captured first. Remaining non-senescent cells were
then scraped from the histology slide. Senescent and
non-senescent cells were then processed for microarray
analysis as described below.
Microarray Analysis
Samples were prepared per instructions in the Paradise
Reagent System (Arcturus Bioscience, Inc., Mountain
View, CA) for steps 1 to 4 and the Affymetrix GeneChip
Expression Analysis Technical Manual (copyright 2002,
Affymetrix, Inc., Rev. 3, Part number 701021) for steps
5 and later. Briefly, the major steps were: 1) Total RNA
was extracted from the isolated cells; 2) The total
extracted RNA was converted to double-stranded
cDNA; 3) cDNA was expressed as cRNA by in vitro
transcription; 4) cRNA was used to prime a second
round of cDNA synthesis; 5) The second-round cDNA
was expressed as biotin-labeled cRNA with the Affyme-
trix 3’ Amplification Reagents for IVT Labeling (Affyme-
trix, P/N 900449); 6) Biotin-labeled cRNA was
fragmented non-enzymatically.
The Affymetrix human U133 X3P array, with probes
for 47,000 human transcripts with all probe sets within
3 0 0b a s ep a i r so ft h e3 ’ end of the transcript, was used
in this study since this specialized design permits the
quantification of fragmented RNA from paraffin-
embedded tissue. The GCOS Affymetrix GeneChip
Operating System (version 1.2, Affymetrix, Santa Clara,
CA) was used for determining gene expression levels.
Microarray data used in the present study can be
viewed in the study named GSE17077 study at the fol-
lowing website: http://www.ncbi.nlm.nih.gov/geo/query/
acc.cgi?acc=GSE17077.
Statistical Analyses
GeneSifter™ web-based software (VizX Labs, Seattle,
WA, USA; http://www.genesifter.net) was used to ana-
lyze all microarray data. Using GC-RMA (Robust multi-
array average), Affymetrix ‘.cel’ files were uploaded to
the GeneSifter™ web site and normalized. Using the stu-
dent t-test (2 tailed, unpaired), statistical significance
w a sd e t e r m i n e d( p<0 . 0 5 ) .T h ef o l dc h a n g ew a ss e ta t
1.02. Gene Ontologies (GO) were generated by GeneSif-
ter™ based on the Gene Ontology Consortium (http://
www.geneontology.org/GO.doc.html[30]).
Results
Identification of Senescent Cells Using Senescence-
Associated-b-galactosidase Immunolocalization Does Not
Significantly Differ from Identification Using
Histochemical Senescence Detection
In the experimental design utilized here, LCM was
employed to separately harvest senescent and non-
senescent cells from paraffin sections of human disc tis-
sue. The traditional histochemical pH 6.0 staining
method routinely for identification of senescent cultured
cells [31,32] unfortunately does not work on paraffin-
embedded tissue. Therefore, senescent cells were identi-
fied here based on immunofluorescent localization of
senescence-Associated-b-galactosidase (Figure 1A). We
carried out an initial study to confirm that the immuno-
histochemical method for identification of senescent
cells did not statistically differ from the histochemical
staining of senescent cells.
This analysis required use of cultured cells. Annulus
cells were cultured from four surgical disc specimens as
previously described [28], cells expanded, and cultured
on multi chamber slides. Replicate cultures of control
cells, and cells induced into senescence via oxidative
stress [29], were then assessed using the histochemical
method or the immunohistochemical methodology
involving localization of senescence-associated-b-galac-
tosidase [19]. There was no statistically significant differ-
ence in the % of senescent cells in our in vitro study for
either control cells, or cells induced into premature
stress-induced senescence by H2O2 exposure (Figure
1B). This in vitro work validated our use of the immu-
nocytochemistry to localize senescent cells for LCM har-
vest and subsequent microarray analysis.
Clinical Study Population
Eleven annulus specimens, Thompson grade 3-4, were
utilized to harvest senescent and non-senescent cells
from the human annulus. Table 1 presents the demo-
graphic features of the subjects, and the percentages of
senescent cells, in the discs evaluated here.
Microarray Analysis
Analysis of genes with significant differences in expres-
sion levels in senescent cells vs non-senescent cells
showed that 292 genes were upregulated, and 321
downregulated. We further analyzed expression patterns
using ontology analyses for genes involved in cell prolif-
eration, in ECM formation and in ECM degradation,
cell adhesion, cell signaling, apoptosis, and genes related
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present study can be viewed in the study named
GSE17077 study at the following website: http://www.
ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE17077.
Major findings are listed below.
Genes Related to Cell Senescence or Cell Proliferation
with Significant Expression Differences in Senescent vs.
Non-Senescent Annulus Cells
One major focus of our gene analysis centered upon
genes known to have a previously established role in cell
senescence (Table 2).
Several genes related to senescence were found to be
significantly upregulated in senescent cells vs. non-senes-
cent cells: p38 (MPAK14), RB-Associated KRAB zinc fin-
ger, Discoidin, CUB and LCCL domain, growth arrest
and DNA-damage inducible beta, inhibitor of growth
family member 5 (p28ING5), sphingosine-1-phosphate
receptor 2 and somatostatin receptor 3. Another known
gene related to senescence, cyclin-dependent kinase 8,
showed significant downregulation in senescent cells.
Nitric oxidase synthase 1, and heat shock 70 kDa protein
6, both of which were significantly down-regulated in
senescent cells, also showed significant changes.
A number of genes related to the cell cycle or cell
proliferation were identified which showed significant
differences in senescent vs. non-senescent cells (Table
3). Significantly upregulated genes included bone mor-
phogenetic protein receptor, type II (serine/threonine
kinase), and protein tyrosine phosphatase, receptor type
A. Several significantly downregulated genes were also
found to be present in the senescent cells; these
included alpha-2-glycoprotein 1, tumor necrosis factor
superfamily, member 13b, integrin-linked kinase-2, the
G1 to S phase transition 2 gene, cell division cycle 2-
like 6 (CDK8-like) gene, and Ras homolog gene family
member H.
Figure 1 A: Localization of senescent cells (red; bold arrows) and non-senescent cells (thin arrows) using immunofluorescent
localization of senescent-associated-b-galactosidase in paraffin-embedded human annulus tissue. (Bar = 10 μm). B: No significant
difference was identified in vitro when control or H2O2-treated annulus cells were quantified using histochemical (H) vs. the immunofluoresce (I)
method to detect senescent cells.
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Senescent vs Non-senescent Annulus Cells
Because senescent cells remain metabolically active even
through they can no longer divide, we were also inter-
ested in other gene expression patterns in senescent
annulus cells, and in how these patterns differed from
those in non-senescent cells.
Table 4 summarizes significantly different expression
patterns for genes related to extracellular matrix (ECM)
formation and degradation, expression of growth factors
and genes related to inflammation, genes related to cells
signaling, and those to apoptosis.
Fibronectin type III and keratin 79, keratin associated
protein 4-11, thrombospondin type I, domain contain 4,
and spondin 1 (an ECM protein) were downregulated in
senescent cells. Two matrix metalloproteinase were
upregulated (MMP2 and an MIFR1), whereas ADAM
metallopeptidase domain 3A was significantly
downregulated.
Two genes related to fibroblast growth factor (FGF)
showed significant differences in senescent cells (FGF %
was downregulated, and FGF-receptor 2 was up-regu-
lated). Significant upregulation was seen for bone mor-
phogenetic protein-2 inducible kinase and interleukin
17C. Interleukin 25 and nitric oxide synthase 1 were
downregulated.
Three important genes related to cell signaling showed
significant downregulation in senescent cells: Mitogen-
activated protein kinase 8 interacting protein 2, mito-
gen-activated protein kinase kinase kinase 11, and mito-
gen-activated protein kinase 2. Two other cell signaling
genes showed significant upregulation in senescent cells:
Table 2 Senescence-Related Genes with Significant Differences in Gene Expression Levels in Senescent vs. Non-
Senescent Annulus Cells
Gene Name Ratio/Fold Change Direction P value Gene Identifier
RB-associated KRAB zinc finger 1.51 Up 0.022 AW138835
Discoidin, CUB and LCCL domain containing protein 2 1.47 Up 0.038 AW300360
p38 (p38 MAP kinase; MPAK14) 1.37 Up 0.029 AF218033
Inhibitor of growth family, member 5 (p28ING5) 1.18 Up 0.046 BC005370
Growth arrest and DNA-damage-inducible, beta 1.06 Up 0.040 AV658684
Somatostatin receptor 3 1.03 Up 0.048 NM_001051
Interferon induced transmembrane protein 1 (9-27) 1.08 Up 0.038 NM_003641
Sphingosine-1-phosphate receptor 2 1.38 Up 0.046 NM_004230
Cyclin-dependent kinase 8 (CDK8) 1.12 Down 0.049 NM_001260
Nitric oxide synthase 1 1.06 Down 0.017 U31466
Heat shock 70 kDa protein 6 (HSP70B) 1.11 Down 0.020 X51757
Table 3 Cell Proliferation or Cell Cycle Genes with Significant Expression Differences in Senescent vs. Non-Senescent
Annulus Cells
Gene Name Ratio/Fold Change Direction P value Gene Identifier
Protein tyrosine phosphatase, receptor type, A 1.68 Up 0.043 BF740139
Kallikrein-related peptidase 4 1.44 Up 0.025 AF113140
Leucine zipper, putative tumor suppressor 1 1.35 Up 0.033 BE312985
Leucine zipper, putative tumor suppressor 1 1.35 Up 0.033 BE312985
SPEG complex locus 1.26 Up 0.040 AL512705
KIAA1009 1.25 Up 0.042 NM_014895
Bone morphogenetic protein receptor, type II (serine/threonine kinase) 1.15 Up 0.023 U20165
Pyrin and HIN domain family, member 1 1.58 Down 0.005 AK024890
Alpha-2-glycoprotein 1, zinc-binding 1.23 Down 0.041 D90427
Arachidonate 15-lipoxygenase 1.21 Down 0.040 NM_001140
Ras homolog gene family, member H 1.17 Down 0.046 NM_004310
Cell division cycle 2-like 6 (CDK8-like) 1.16 Down 0.016 AA994004
Tumor necrosis factor (ligand) superfamily, member 13b 1.13 Down 0.024 AF134715
Triple functional domain (PTPRF interacting) 1.13 Down 0.027 BF223718
Sialophorin (leukosialin, CD43) 1.07 Down 0.042 J04168
G1 to S phase transition 2 1.04 Down 0.018 NM_018094
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Senescent cells showed significant downregulation of
three genes related to apoptosis: BCL2/adenovirus E1B
interacting proteins 2 and 3, and apoptotic peptidase
activating factor 1.
Significant changes were also present in senescent
cells in a number of genes related to solute transport,
ribosomal proteins, zinc finger proteins, and other genes
(Additional file 1: Table S1). Aquaporin 6 and ATG4
autophagy related 4 homolog B were significantly down-
regulated in senescent cells.
Discussion
In this study we utilized LCM to separately harvest
senescent and non-senescent cells in paraffin-embedded
section of human annulus tissue from the intervertebral
discs. LCM harvests produced mRNA in amounts which
could then be utilized in whole genome microarray ana-
lysis. This application of LCM to selectively isolate
senescent cells was especially important in our work
because this is the only methodology whereby senes-
cence cells can currently be separated from non-senes-
cent cells in tissue. Researchers who are experienced
with harvest of individual cells using laser capture
microdissection will be able to carry out studies such as
ours since senescent cells were readily visualized with
the fluorescent microscopy as illustrated in Figure 1. We
look forward to future LCM studies which also include
real-time RT-PCR analysis of genes identified in our
present work.
There is a known loss of cells in the aging and degen-
erating human disc; understanding senescent cells is
important since their presence further reduces the disc’s
ability to generate new cells to replace those lost to
necrosis or apoptosis.
Senescent cells, compared to those which were non-
senescent, showed significant upregulation of a number
of critical genes which have previously been shown to
play important roles in cell senescence (Table 2).
Our analysis showed that mitogen-activated protein
kinase p38 (also know as p38, p38 MPA kinase or
MPAK14) was significantly upregulated in senescent
compared to non-senescent annulus cells. Mitogen-acti-
vated protein kinase p38 plays an important causative
role in senescent cells following telomere shortening
[33-35]. Although we were not able to assess telomere
length in the present work, important previous studies
by LeMaitre et al [18] documented telomere shortening
in cultured cells derived from degenerating disc
specimens.
We found that senescent annulus cells showed signifi-
cant upregulation of the gene growth arrest and DNA-
damage-inducible beta (also called GADD45beta)
compared to non-senescent cells. This gene is an
upstream activator of the p38MAPK cascade (see above)
[36]. Overexpression of GADD45beta has been shown
to activate p38 via MTK1 [36-38]. Thus the GADD45-
beta gene also contributes to regulating the cell cycle.
Our analysis identified significant upregulation of the
retinoblastoma (Rb)-associated KRAB repressor gene
(also called RBAK) in senescent annulus cells compared
to levels in non-senescent cells. A number of studies
have previously shown that the retinoblastoma protein
enforces permanent cell cycle withdrawal and that this
gene plays a central role in senescence [39,40]. Addi-
tional studies have shown that the retinoblastoma-asso-
ciated KRAB repressor gene contributes to Rb-
dependent of E2F mediated transcriptional activation
and Rb-mediated cell cycle arrest [41].
We found that discoidin, CUB and LCCL domain con-
taining protein 2 was significantly upregulated in senes-
cent annulus cells compared to non-senescent cells.
Studies in vitro using 293T endothelial vascular cells,
have shown that expression of this gene caused suppres-
sion of cell division [42].
Senescent disc cells expressed significantly greater
levels of the gene inhibitor of growth family member 5
than did non-senescent cells. Members of the inhibitor
of growth gene family are tumor suppressors which reg-
ulate cell cycle progression and also apoptosis and DNA
repair; they are important cofactors of p53 [43].
Binding of somatostatin to its receptor has been
shown to initiate G-protein-dependent cell growth arrest
[44]. Our evaluation showed significantly greater expres-
sion of somatostatin receptor 3 in senescent annulus
cells compared to non-senescent cells.
Interferon-induced transmembrane protein 1 has an
important role in the anti-proliferative effects of inter-
feron-gamma [45]. Yang et al. have proposed that it has
its action by inhibiting extracellular signal-regulated
kinase, enhancing the transcriptional activity of p53, and
inhibiting p53 phosphorylation. In our work, we found
that senescent cells had significantly great expression of
interferon-induced transmembrane protein 1 compared
to non-senescent cells.
Sphingosine 1-phosphate is a serum-borne bioactive
sphingolipid which has been shown by Estrada et al. to
have signaling functions in cells [46]. The receptor sub-
types 1-3 for sphinogosine 1-phosphate are also known
to be markedly increased in senescent endothelial cells,
and Estrada et al. have shown that senescence can be
blocked when the receptors are knocked down with
molecular techniques. An series of studies have now
shown that sphingolipids may have an important role in
regulating cell senescence [47-49]. Our studies showed
significant upregulation of sphingosine 1-phosphate
receptor 2 in senescent vs. non-senescent cells.
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known to influence the surrounding microenvironment.
Nitric oxide is a good example of an important media-
tion [50]. In studies by Sato et al. nitric oxide was
shown to be inhibited by senescent endothelial cells
[51], and decreased endothelial nitric oxide synthase
mRNA, protein and activity was found to be greater in
senescent endothelial cells compared to young cells [52].
Differential expression of nitric oxide synthase (eNOS)
in senescent endothelial cells has also been identified by
Bernardini et al. [53]. In our studies, we also identified a
significant decrease in nitric oxide synthase in our
senescent annulus cells compared to the non-senescent
cells.
The p53 network, which is very complex, controls
stress responses such as cell cycle arrest. P21 is a key
mediator of p53-dependent cell cycle arrest. Cyclin-
dependent kinase 8 (CDK8) acts as a stimulus-specific
positive coregulator within the p53 system [54]. Recent
work by Firestein et al. has shown that suppression of
CDK8 expression inhibits proliferation in colon cancer
cells [55]. In our analyses, we found a significant down-
regulation of CDK8 in senescent annulus cells compared
to non-senescent cells.
The group of heat shock proteins (HSP) are stress-
induced, and have a number of members which are now
recognized to be associated with cell senescence, includ-
ing HSP70 which was shown in the present study to be
significantly downregulated in senescent annulus cells
compared to non-senescent cells. Gutsmann-Conrad et
al. have shown that the expression of HSP70 also
decreased with senescence in IMR-90 lung fibroblasts
during in vitro studies of cells from young or old sub-
jects [56] and in senescent human fibroblasts [57]. In
our analyses, we found a significantly reduced expres-
sion of HSP70 protein 6. This finding is important since
this modification of the senescent cell phenotype may
alter the cells ability to withstand hyperthermia and
other different types of physiologic stresses.
Tables 3 and 4 present other genes important to disc
cell function which showed significant differences in
senescent vs. non-senescent annulus cells. Of these, it is
interesting to note that with aging senescence-acceler-
ated mouse (SAM) model shows a change similar to our
finding with respect to the bone morphogenetic protein
type II receptor. Takae et al. found that with the pro-
gression of degeneration this receptor could be found
within annulus cells in this mouse model [58].
In closing, we would like to speak to the relevance and
potential future applications of the findings presented
here. Disc degeneration, and its associated low back
pain, are a primary cause of disability and play a major
role in this country’s medical, social and economic
structure. Estimated costs related to low back disorders
are in the range of $50-100 billion per year in the U.S.
alone [59]. Whether senescent cells are present in the
disc as a result of disc degeneration, as a result of aging,
or are due to as yet unidentified causes, it is now well-
recognized that senescent cells are a important compo-
nent of the disc cell population. A number of recent
studies have shown that cellular senescence can be
reversed, or at least attenuated [29,60-64]. Along with
other researchers in the disc field, we feel that potential
biologic therapies for disc degeneration hold much pro-
mise; information gained in the present study may one
day contribute to future approaches which include anti-
senescence therapies.
Conclusions
The novel data presented here contribute to the under-
standing of senescence in the aging/degenerating disc.
Since senescent cells have lost of the ability to divide,
this further compounds the degenerative process in the
disc. In addition, these senescent cells may be exerting
an influence upon the surrounding microenvironment
and nearby cells. Prominent in our findings of senescent
vs non-senescent in vivo gene expression patterns in
human annulus cells were senescence genes related to
the pRB/p53 and MAP kinase pathways. Our application
of LCM was a critically important experimental techni-
que which allowed us to separately analyze senescent vs
non-senescent cells. Major genes were identified which
have recognized relationships to cell senescence, and
gene-interactions within cellular senescence changes.
Findings reported here may contribute to future biologic
therapies for disc degeneration which include
approaches to prevent cellular senescence.
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